148 related articles for article (PubMed ID: 15189352)
1. Parkin attenuates manganese-induced dopaminergic cell death.
Higashi Y; Asanuma M; Miyazaki I; Hattori N; Mizuno Y; Ogawa N
J Neurochem; 2004 Jun; 89(6):1490-7. PubMed ID: 15189352
[TBL] [Abstract][Full Text] [Related]
2. PINK1/Parkin-mediated mitophagy play a protective role in manganese induced apoptosis in SH-SY5Y cells.
Zhang HT; Mi L; Wang T; Yuan L; Li XH; Dong LS; Zhao P; Fu JL; Yao BY; Zhou ZC
Toxicol In Vitro; 2016 Aug; 34():212-219. PubMed ID: 27091500
[TBL] [Abstract][Full Text] [Related]
3. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.
Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR
Neuron; 2002 Dec; 36(6):1007-19. PubMed ID: 12495618
[TBL] [Abstract][Full Text] [Related]
4. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
Jiang H; Ren Y; Zhao J; Feng J
Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
[TBL] [Abstract][Full Text] [Related]
6. Parkin is recruited to the centrosome in response to inhibition of proteasomes.
Zhao J; Ren Y; Jiang Q; Feng J
J Cell Sci; 2003 Oct; 116(Pt 19):4011-9. PubMed ID: 12928331
[TBL] [Abstract][Full Text] [Related]
7. Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation.
Kitao Y; Imai Y; Ozawa K; Kataoka A; Ikeda T; Soda M; Nakimawa K; Kiyama H; Stern DM; Hori O; Wakamatsu K; Ito S; Itohara S; Takahashi R; Ogawa S
Hum Mol Genet; 2007 Jan; 16(1):50-60. PubMed ID: 17116640
[TBL] [Abstract][Full Text] [Related]
8. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322
[TBL] [Abstract][Full Text] [Related]
9. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.
McNaught KS; Mytilineou C; Jnobaptiste R; Yabut J; Shashidharan P; Jennert P; Olanow CW
J Neurochem; 2002 Apr; 81(2):301-6. PubMed ID: 12064477
[TBL] [Abstract][Full Text] [Related]
10. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
11. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
12. A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin.
Omura T; Kaneko M; Okuma Y; Orba Y; Nagashima K; Takahashi R; Fujitani N; Matsumura S; Hata A; Kubota K; Murahashi K; Uehara T; Nomura Y
J Neurochem; 2006 Dec; 99(6):1456-69. PubMed ID: 17059562
[TBL] [Abstract][Full Text] [Related]
13. NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.
Korutla L; Furlong HA; Mackler SA
Neuroscience; 2014 Jan; 257():86-95. PubMed ID: 24231739
[TBL] [Abstract][Full Text] [Related]
14. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells.
Shamoto-Nagai M; Maruyama W; Kato Y; Isobe K; Tanaka M; Naoi M; Osawa T
J Neurosci Res; 2003 Nov; 74(4):589-97. PubMed ID: 14598303
[TBL] [Abstract][Full Text] [Related]
15. Cell type-specific upregulation of Parkin in response to ER stress.
Wang HQ; Imai Y; Kataoka A; Takahashi R
Antioxid Redox Signal; 2007 May; 9(5):533-42. PubMed ID: 17465879
[TBL] [Abstract][Full Text] [Related]
16. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS
Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198
[TBL] [Abstract][Full Text] [Related]
17. Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.
Rosen KM; Moussa CE; Lee HK; Kumar P; Kitada T; Qin G; Fu Q; Querfurth HW
J Neurosci Res; 2010 Jan; 88(1):167-78. PubMed ID: 19610108
[TBL] [Abstract][Full Text] [Related]
18. Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson's disease model.
Ham S; Lee YI; Jo M; Kim H; Kang H; Jo A; Lee GH; Mo YJ; Park SC; Lee YS; Shin JH; Lee Y
Sci Rep; 2017 Apr; 7(1):525. PubMed ID: 28366931
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells.
Kyratzi E; Pavlaki M; Kontostavlaki D; Rideout HJ; Stefanis L
J Neurochem; 2007 Aug; 102(4):1292-303. PubMed ID: 17472700
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons.
Son JH; Kawamata H; Yoo MS; Kim DJ; Lee YK; Kim S; Dawson TM; Zhang H; Sulzer D; Yang L; Beal MF; Degiorgio LA; Chun HS; Baker H; Peng C
J Neurochem; 2005 Aug; 94(4):1040-53. PubMed ID: 16092945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
